Anuh Pharma Ltd vs Bharat Immunological Biological Corporation Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Anuh Pharma Ltd is ₹ 85.43 as of 05 May 15:30 . The P/E Ratio of Anuh Pharma Ltd changed from 15.9 on March 2021 to 15.8 on March 2025 . This represents a CAGR of -0.13% over 5 yearsThe P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Anuh Pharma Ltd changed from ₹ 452.51 crore on March 2021 to ₹ 745.92 crore on March 2025 . This represents a CAGR of 10.51% over 5 yearsThe Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 196.47 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 years The revenue of Anuh Pharma Ltd for the Dec '25 is ₹ 201.29 crore as compare to the Sep '25 revenue of ₹ 186.86 crore. This represent the growth of 7.72% The revenue of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Anuh Pharma Ltd for the Dec '25 is ₹ 20.91 crore as compare to the Sep '25 ebitda of ₹ 12.86 crore. This represent the growth of 62.6% The ebitda of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The net profit of Anuh Pharma Ltd changed from ₹ 9.51 crore to ₹ 13.45 crore over 7 quarters. This represents a CAGR of 21.91% The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The Dividend Payout of Anuh Pharma Ltd changed from 26.43 % on March 2021 to 15.88 % on March 2025 . This represents a CAGR of -9.69% over 5 yearsThe Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Anuh Pharma Ltd

Anuh Pharma Limited is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs).
The Company is engaged in the business of manufacturing and selling of 'Bulk drugs and chemicals.
The company is part of the SK Group with the key products including antibiotics, erythromycin salts, chloramphenicol and other chemicals.
It is well positioned to service its existing and potential markets through its manufacturing operations at Tarapur in Maharashtra. The Company was incorporated on February 19, 1960.
The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra.

About Bharat Immunological & Biological Corporation Ltd

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
BIBCOL was incorporated in 1989.
The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
BIBCL installed a plant of 100 mln units.
Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

FAQs for the comparison of Anuh Pharma Ltd and Bharat Immunological & Biological Corporation Ltd

Which company has a larger market capitalization, Anuh Pharma Ltd or Bharat Immunological & Biological Corporation Ltd?

Market cap of Anuh Pharma Ltd is 856 Cr while Market cap of Bharat Immunological & Biological Corporation Ltd is 74 Cr

What are the key factors driving the stock performance of Anuh Pharma Ltd and Bharat Immunological & Biological Corporation Ltd?

The stock performance of Anuh Pharma Ltd and Bharat Immunological & Biological Corporation Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Anuh Pharma Ltd and Bharat Immunological & Biological Corporation Ltd?

As of May 5, 2026, the Anuh Pharma Ltd stock price is INR ₹85.43. On the other hand, Bharat Immunological & Biological Corporation Ltd stock price is INR ₹17.33.

How do dividend payouts of Anuh Pharma Ltd and Bharat Immunological & Biological Corporation Ltd compare?

To compare the dividend payouts of Anuh Pharma Ltd and Bharat Immunological & Biological Corporation Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.